MIGRAINE outcomes improved for many individuals over 1 year in a longitudinal population study.
Improvements were associated with fewer headache days, reduced disability, better quality-of-life, improved workplace functioning, and lower perceived stigma.
Researchers analysed data from 11,634 adults with migraine who completed both baseline and 1 year follow-up surveys in the Observational survey of the Epidemiology, treatment, and Care Of MigrainE (OVERCOME) study.
Overall migraine status was determined using changes in monthly headache days, Migraine Disability Assessment Scale (MIDAS) scores, and Migraine-Specific Quality-of-Life Questionnaire Role Function Restrictive (MSQ-RFR) scores.
At 1 year, 40.4% of participants were classified as “overall improved”, 24.1% as “overall worsened”, and 35.5% as showing “no net change”.
Individuals in the improved group experienced reductions in monthly headache days. They also reported lower disability, alongside improved quality of life.
Worsening Migraine Linked to Greater Burden
Participants whose migraine status worsened experienced the opposite pattern. Monthly headache days increased and role function restrictive scores declined.
The worsening group also showed greater disease burden across several patient-reported outcomes.
Researchers observed increased interictal burden, poorer emotional functioning, and a greater negative impact on work productivity and daily activities.
Individuals in this group were also more likely to require both acute and preventive migraine treatment.
In contrast, those whose migraine improved generally reported favourable changes across multiple domains that were not included in the study classification criteria, suggesting broader benefits associated with improvements in migraine status.
Impact on Work Productivity and Clinical Care
Workplace outcomes differed substantially between groups. Participants with improved migraine status reported reductions in activity impairment, presenteeism, and overall productivity loss.
They also experienced less migraine related stigma and were less likely to conceal their condition.
Medication patterns reflected these changes. The improved group demonstrated reduced medication need and lower rates of acute medication overuse.
Meanwhile, participants with worsening migraine showed increased treatment requirements.
The findings highlighted the substantial effects that changes in migraine have on physical function, emotional wellbeing, workplace productivity, treatment needs, and perceived stigma, reinforcing the value of timely diagnosis and treatment optimisation.
Reference
Buse DC et al. Changes in Migraine-Related Outcomes and Functioning at 1 Year: Results of the Longitudinal OVERCOME (US) Study. Neurol Ther. 2026;DOI:10.1007/s40120-026-00946-8
Featured image: fizkes on Adobe Stock
Disclaimer: This content has not been generated, created or edited by Finance SC. Publisher:
Source link
Source link
